A phase 2 study of ET-743 [trabectedin] in subjects with advanced breast cancer
Phase of Trial: Phase II
Latest Information Update: 27 Apr 2011
At a glance
- Drugs Trabectedin (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 27 Apr 2011 Actual end date (Dec 2006) added as reported by ClinicalTrials.gov.
- 27 Apr 2011 Actual initiation date changed from Nov 2003 to Dec 2002 as reported by ClinicalTrials.gov.
- 25 Sep 2007 Status changed from in progress to completed.